Literature DB >> 4169440

Studies on the control of antibody synthesis. II. Effect of antigen dose and of suppression by passive antibody on the affinity of antibody synthesized.

G W Siskind, P Dunn, J G Walker.   

Abstract

The effect of antigen dose on the kinetics of circulating antibody synthesis and on antibody affinity was studied in a haptenic system. High doses of antigen resulted, early in immunization, in higher concentrations of antibody followed later in the immune response by decreased serum levels of antibody as compared with lower doses of antigen. The affinity of the initial antibody synthesized was very similar over a wide antigen dose range. Subsequently, however, a rapid rise in affinity was seen in animals immunized with low doses of antigen, while relatively little change in affinity was seen in animals immunized with higher antigen doses. Suppression of active antibody formation by passive antiserum led to an increase in antibody affinity. The results are discussed in terms of the mechanisms involved in the selection of a population of cells to participate in the immune response and the mechanisms whereby antigen dose and circulating antibody function to control antibody synthesis.

Mesh:

Substances:

Year:  1968        PMID: 4169440      PMCID: PMC2138429          DOI: 10.1084/jem.127.1.55

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  16 in total

1.  Studies of hypersensitivity to low molecular weight substances. III. The 2,4-dinitrophenyl group as a determinant in the preciptin reaction.

Authors:  H N EISEN; M E CARSTEN; S BELMAN
Journal:  J Immunol       Date:  1954-11       Impact factor: 5.422

2.  EXCITATION ENERGY TRANSFER AND THE QUANTITATIVE STUDY OF THE ANTIBODY HAPTEN REACTION.

Authors:  S F Velick; C W Parker; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1960-11       Impact factor: 11.205

3.  Spectrometric evaluation of the approximate pK of the carboxyl group in 2,4-dinitrophenyl-amino acids.

Authors:  L K RAMACHANDRAN; L V SASTRY
Journal:  Biochemistry       Date:  1962-01       Impact factor: 3.162

Review 4.  The immune response to a simple antigenic determinant.

Authors:  H N Eisen
Journal:  Harvey Lect       Date:  1966

5.  Antibody synthesis at the cellular level. Antibody-induced suppression of 7S antibody synthesis.

Authors:  H Wigzell
Journal:  J Exp Med       Date:  1966-11-01       Impact factor: 14.307

6.  The preparation and some properties of purified antibody specific for the 2,4-dinitrophenyl group.

Authors:  F S FARAH; M KERN; H N EISEN
Journal:  J Exp Med       Date:  1960-12-01       Impact factor: 14.307

7.  HOMEOSTASIS OF ANTIBODY FORMATION IN THE ADULT RAT.

Authors:  D A ROWLEY; F W FITCH
Journal:  J Exp Med       Date:  1964-12-01       Impact factor: 14.307

8.  Studies on the control of antibody synthesis. Interaction of antigenic competition and suppression of antibody formation by passive antibody on the immune response.

Authors:  N I Brody; J G Walker; G W Siskind
Journal:  J Exp Med       Date:  1967-07-01       Impact factor: 14.307

9.  A study of the distribution of 2,4-dinitrobenzene sensitizers between isolated lymph node cells and extracellular medium in relation to induction of contact skin sensitivity.

Authors:  H N EISEN; M KERN; W T NEWTON; E HELMREICH
Journal:  J Exp Med       Date:  1959-08-01       Impact factor: 14.307

10.  Antihapten antibody specificity and L chain type.

Authors:  V Nussenzweig; B Benacerraf
Journal:  J Exp Med       Date:  1967-10-01       Impact factor: 14.307

View more
  29 in total

1.  The extent of affinity maturation differs between the memory and antibody-forming cell compartments in the primary immune response.

Authors:  K G Smith; A Light; G J Nossal; D M Tarlinton
Journal:  EMBO J       Date:  1997-06-02       Impact factor: 11.598

2.  The adoptive secondary response to human serum albumin under conditions of high antigen pressure. The response of high and low avidity B cell subsets.

Authors:  E B Bell; F L Shand
Journal:  Immunology       Date:  1977-10       Impact factor: 7.397

3.  Effect of carrier priming on antibody avidity in the in vivo and in vitro immune response.

Authors:  G Doria; G Agarossi; D Boraschi; M Antonietta
Journal:  Immunology       Date:  1977-04       Impact factor: 7.397

4.  Regulation of the immune response. VI. Inability of F(ab') 2 antibody to terminate established immune responses and its ability to interfere with IgG antibody-mediated immunosuppression.

Authors:  P L Chan; N R Sinclair
Journal:  Immunology       Date:  1973-02       Impact factor: 7.397

5.  Degeneracy of the immune response to sheep red cells. Thymic dependency.

Authors:  R K Gershon; K Kondo
Journal:  Immunology       Date:  1972-09       Impact factor: 7.397

6.  Antigenic competition in vitro of spleen cells subjected to a graft-versus-host reaction.

Authors:  O Sjöberg
Journal:  Immunology       Date:  1971-08       Impact factor: 7.397

7.  The generation of antibody diversity. I. Studies on the population distribution of anti-DNP antibody affinities and on the influence of allotype on antibody affinity and concentration.

Authors:  T P Werblin; Y T Kim; R Mage; B Benacerraf; G W Siskind
Journal:  Immunology       Date:  1973-07       Impact factor: 7.397

8.  Studies on the control of antibody synthesis. VI. Effect of antigen dose and time after immunization on antibody affinity and heterogeneity in the mouse.

Authors:  Y T Kim; G W Siskind
Journal:  Clin Exp Immunol       Date:  1974-06       Impact factor: 4.330

9.  Affinity of antigen for white cells and its relation to the induction of antibody formation.

Authors:  D Sulitzeanu
Journal:  Bacteriol Rev       Date:  1968-12

10.  Studies on the control of antibody synthesis. VII. Change in affinity of direct and indirect plaque-forming cells with time after immunization in the mouse: loss of high affinity plaques late after immunization.

Authors:  E A Goidl; J J Barondess; G W Siskind
Journal:  Immunology       Date:  1975-10       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.